亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Mouse obesity model: Mito-OB™ mouse

详细技术说明
Dr. Mishra’s mouse model;  Mito-OB ® has a specific alteration of prohibitin gene expression in white adipose tissue.  Animals become obese and insulin resistant in a manner analogous to human obesity, diabetes and metabolic syndrome.  Existing mouse obesity molecules are based on appetite dysregulation by the leptin system or un-defined characteristics of obesity-selected strains.   For this reason the results of pharmacology and other therapeutic experiments on currently-available mouse obesity models may be  misleading or even useless.
*Abstract

Mito-OB ® mouse model elucidates the regulation of adipose tissue homeostasis and its impact on metabolic regulation. This transgenic mouse model, Mito-Ob®, over-expresses prohibitin (PHB) in adipocytes. Mito-Ob® mice developed obesity due to up-regulation of mitochondrial biogenesis in adipocytes. Mito-Ob®  female mice developed more visceral fat than male mice. MitoOb® male mice had impaired glucose homeostasis, compromised brown adipose tissue structure, and high insulin and low adiponectin levels.  Mechanistically, the inventors found that PHB overexpression enhances the cross talk between the mitochondria and the nucleus as well as it facilitates mitochondrial biogenesis. The data suggest a critical role of PHB and adipocyte mitochondria in adipose tissue homeostasis and reveal sex differences in the effect of PHB-induced adipocyte mitochondrial remodeling on whole-body metabolism. Targeting adipocyte mitochondria may provide new therapeutic opportunities for the treatment of obesity, a major risk factor for type 2 diabetes.  The transgenic mice provide a heretofore unavailable animal model (with a well defined metabolic defect) of obesity, insulin resistance and metabolic syndrome. In contrast, existing mouse obesity molecules are based on appetite dysregulation by the leptin system or un-defined characteristics of obesity-selected strains.

*Inquiry
Odd Bres,Ph.D.TechnologyManagerPh:+1(204)474.9407Email: odd.bres@umanitoba.ca
国家/地区
美国

欲了解更多信息,请点击 这里
移动设备